GCG and Insulin resistance: When the activation of the aromatic hydrocarbon pathway is defective, host GLP-1 and IL-22 production is reduced, intestinal permeability is altered, and lipopolysaccharide translocation is promoted, leading to host inflammation, insulin resistance, and hepatic steatosis (118).